Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations
- 25 February 2005
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 96 (3) , 167-175
- https://doi.org/10.1111/j.1742-7843.2005.pto960305.x
Abstract
Drug metabolism profoundly affects drug action, because almost all drugs are metabolised in the body and thus their concentrations and elimination rates are dependent on metabolic activity. Drug metabolism contributes substantially to interindividual differences in drug response and is also often involved in drug interactions, resulting in either therapeutic failure or adverse effects. Knowledge about the metabolism of a new chemical entity and its affinity to drug-metabolising enzymes helps in the drug development process by providing important information for the selection of a lead compound from among a number of substances pharmacologically equally effective in their therapeutic response. In drug development protocols, metabolism characteristics should be assessed very early during the development process. This has been made possible by the advances made especially in analytical capabilities and in in vitro technologies that are employed to predict in vivo metabolite profile, pharmacokinetic parameters and drug-drug interaction potential.Keywords
This publication has 30 references indexed in Scilit:
- Database analyses for the prediction of in vivo drug–drug interactions from in vitro dataBritish Journal of Clinical Pharmacology, 2004
- COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMSDrug Metabolism and Disposition, 2003
- Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug MetabolismClinical Pharmacokinetics, 2003
- Progress Towards Prediction of Human Pharmacokinetic Parameters from In Vitro TechnologiesDrug Metabolism Reviews, 2003
- Metabolic Stability for Drug Discovery and DevelopmentClinical Pharmacokinetics, 2003
- Introductory remarks on human CYPsDrug Metabolism Reviews, 2002
- Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derivedin vitrosystemsXenobiotica, 2001
- High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- QUANTITATIVE PREDICTION OF IN VIVO DRUG CLEARANCE AND DRUG INTERACTIONS FROM IN VITRO DATA ON METABOLISM, TOGETHER WITH BINDING AND TRANSPORTAnnual Review of Pharmacology and Toxicology, 1998
- Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver SlicesDrug Metabolism Reviews, 1997